Ravi Salgia Department of Medicine University of Chicago Biography Publications Institution JoVE Articles Ravi Salgia has not added a biography. If you are Ravi Salgia and would like to personalize this page please email our Author Liaison for assistance. Publications Inhibition of Mitochondrial Fission Prevents Cell Cycle Progression in Lung Cancer The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Feb, 2012 | Pubmed ID: 22321727 Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Feb, 2012 | Pubmed ID: 22198429 Characterization of NOL7 Gene Point Mutations, Promoter Methylation, and Protein Expression in Cervical Cancer International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. Jan, 2012 | Pubmed ID: 22123719 Prognostic Value of Metabolic Tumor Burden on 18F-FDG PET in Nonsurgical Patients with Non-small Cell Lung Cancer European Journal of Nuclear Medicine and Molecular Imaging. Jan, 2012 | Pubmed ID: 21946983 MET and Phosphorylated MET As Potential Biomarkers in Lung Cancer Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 2011 | Pubmed ID: 22181983 Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial Clinical Lung Cancer. Nov, 2011 | Pubmed ID: 22100149 Role of MetMAb (OA-5D5) in C-MET Active Lung Malignancies Expert Opinion on Biological Therapy. Dec, 2011 | Pubmed ID: 22047509 MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma with Evidence of Responsiveness to Crizotinib Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Dec, 2011 | Pubmed ID: 22042947 Inhibition of MET Receptor Tyrosine Kinase and Its Ligand Hepatocyte Growth Factor Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Nov, 2011 | Pubmed ID: 22005540 Effect of Crizotinib on Overall Survival in Patients with Advanced Non-small-cell Lung Cancer Harbouring ALK Gene Rearrangement: a Retrospective Analysis The Lancet Oncology. Oct, 2011 | Pubmed ID: 21933749 The Role of the C-Met Pathway in Lung Cancer and the Potential for Targeted Therapy Therapeutic Advances in Medical Oncology. Jul, 2011 | Pubmed ID: 21904579 Prognostic Significance of Angiogenesis and Angiogenic Growth Factors in Nonsmall Cell Lung Cancer Cancer. Sep, 2011 | Pubmed ID: 21858799 Bortezomib for Patients with Advanced-stage Bronchioloalveolar Carcinoma: a California Cancer Consortium Phase II Study (NCI 7003) Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Oct, 2011 | Pubmed ID: 21716143 Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2011 | Pubmed ID: 21712447 Autotaxin Induces Lung Epithelial Cell Migration Through LysoPLD Activity-dependent and -independent Pathways The Biochemical Journal. Oct, 2011 | Pubmed ID: 21696367 Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. May, 2011 | Pubmed ID: 21623265 An E3 Ubiquitin Ligase: C-Cbl: a New Therapeutic Target of Lung Cancer Cancer. Dec, 2011 | Pubmed ID: 21607942 Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients with Medullary Thyroid Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2011 | Pubmed ID: 21606412 Proteomic Characterization of Non-small Cell Lung Cancer in a Comprehensive Translational Thoracic Oncology Database Journal of Clinical Bioinformatics. Feb, 2011 | Pubmed ID: 21603121 Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Aug, 2011 | Pubmed ID: 21597387 RON (MST1R) is a Novel Prognostic Marker and Therapeutic Target for Gastroesophageal Adenocarcinoma Cancer Biology & Therapy. Jul, 2011 | Pubmed ID: 21543897 Takotsubo Cardiomyopathy in a Patient with Squamous Cell Esophageal Carcinoma Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2011 | Pubmed ID: 21519014 Personalized Treatment of Lung Cancer Seminars in Oncology. Apr, 2011 | Pubmed ID: 21421117 Role of Protein Kinase C β and Vascular Endothelial Growth Factor Receptor in Malignant Pleural Mesothelioma: Therapeutic Implications and the Usefulness of Caenorhabditis Elegans Model Organism Journal of Carcinogenesis. 2011 | Pubmed ID: 21383961 Fyn is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2011 | Pubmed ID: 21364031 Functional EGFR Germline Polymorphisms May Confer Risk for EGFR Somatic Mutations in Non-small Cell Lung Cancer, with a Predominant Effect on Exon 19 Microdeletions Cancer Research. Apr, 2011 | Pubmed ID: 21292812 Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-line Treatment in Patients with Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Apr, 2011 | Pubmed ID: 21289521 The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression: a Laboratory Investigation Anesthesia and Analgesia. Mar, 2011 | Pubmed ID: 21156980 Paxillin Expression and Amplification in Early Lung Lesions of High-risk Patients, Lung Adenocarcinoma and Metastatic Disease Journal of Clinical Pathology. Jan, 2011 | Pubmed ID: 21045234 Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (crizotinib, PF02341066) in an ALK Translocation-positive Patient with Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Dec, 2010 | Pubmed ID: 21102269 Expression Patterns of PAX5, C-Met, and Paxillin in Neuroendocrine Tumors of the Lung Archives of Pathology & Laboratory Medicine. Nov, 2010 | Pubmed ID: 21043826 Anaplastic Lymphoma Kinase Inhibition in Non-small-cell Lung Cancer The New England Journal of Medicine. Oct, 2010 | Pubmed ID: 20979469 Novel Oncogenic Mutations of CBL in Human Acute Myeloid Leukemia That Activate Growth and Survival Pathways Depend on Increased Metabolism The Journal of Biological Chemistry. Oct, 2010 | Pubmed ID: 20622007 DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCER Current Proteomics. Apr, 2010 | Pubmed ID: 20526421 Phase II Study of Amrubicin As Second-line Therapy in Patients with Platinum-refractory Small-cell Lung Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2010 | Pubmed ID: 20385980 EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation The Journal of Biological Chemistry. Jun, 2010 | Pubmed ID: 20360610 Methylnaltrexone Potentiates the Anti-angiogenic Effects of MTOR Inhibitors Journal of Angiogenesis Research. 2010 | Pubmed ID: 20298531 Fyn: a Novel Molecular Target in Cancer Cancer. Apr, 2010 | Pubmed ID: 20151426 The Role of Chemokine Receptor CXCR4 in Lung Cancer Cancer Biology & Therapy. Mar, 2010 | Pubmed ID: 20147779 MET Molecular Mechanisms and Therapies in Lung Cancer Cell Adhesion & Migration. Jan-Mar, 2010 | Pubmed ID: 20139696 CBL is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases PloS One. 2010 | Pubmed ID: 20126411 PAX3 and SOX10 Activate MET Receptor Expression in Melanoma Pigment Cell & Melanoma Research. Apr, 2010 | Pubmed ID: 20067553 The MET Axis As a Therapeutic Target Update on Cancer Therapeutics. Apr, 2009 | Pubmed ID: 20368753 MET/PKCbeta Expression Correlate with Metastasis and Inhibition is Synergistic in Lung Cancer Journal of Carcinogenesis. 2009 | Pubmed ID: 19955662 The Role of EGFR Inhibition in the Treatment of Non-small Cell Lung Cancer The Oncologist. Nov, 2009 | Pubmed ID: 19892771 MET Receptor Tyrosine Kinase Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Nov, 2009 | Pubmed ID: 19861919 MET, HGF, EGFR, and PXN Gene Copy Number in Lung Cancer Using DNA Extracts from FFPE Archival Samples and Prognostic Significance Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 2009 | Pubmed ID: 19817696 Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-mesenchymal Transition Cancer Research. Oct, 2009 | Pubmed ID: 19738072 Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2009 | Pubmed ID: 19723643 PAX6 is Expressed in Pancreatic Cancer and Actively Participates in Cancer Progression Through Activation of the MET Tyrosine Kinase Receptor Gene The Journal of Biological Chemistry. Oct, 2009 | Pubmed ID: 19651775 Role of C-Met in Cancer: Emphasis on Lung Cancer Seminars in Oncology. Apr, 2009 | Pubmed ID: 19393836 MET Pathway As a Therapeutic Target Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Apr, 2009 | Pubmed ID: 19333071 The MET Receptor Tyrosine Kinase is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma Cancer Research. Apr, 2009 | Pubmed ID: 19318576 PAX5 is Expressed in Small-cell Lung Cancer and Positively Regulates C-Met Transcription Laboratory Investigation; a Journal of Technical Methods and Pathology. Mar, 2009 | Pubmed ID: 19139719 FYN is Overexpressed in Human Prostate Cancer BJU International. Jan, 2009 | Pubmed ID: 18990162 MET As a Target for Treatment of Chest Tumors Lung Cancer (Amsterdam, Netherlands). Feb, 2009 | Pubmed ID: 18672314 Biomarkers in Lung Cancer: from Early Detection to Novel Therapeutics and Decision Making Biomarkers in Medicine. Dec, 2008 | Pubmed ID: 19802373 Synergism of EGFR and C-Met Pathways, Cross-talk and Inhibition, in Non-small Cell Lung Cancer Journal of Carcinogenesis. 2008 | Pubmed ID: 19240370 Lymphatic Vessel Density is Not Associated with Lymph Node Metastasis in Non-small Cell Lung Carcinoma Archives of Pathology & Laboratory Medicine. Dec, 2008 | Pubmed ID: 19061284 Stamp out Lung Cancer Journal of Carcinogenesis. 2008 | Pubmed ID: 19008566 EGFR-targeted Therapeutics: Focus on SCCHN and NSCLC TheScientificWorldJournal. 2008 | Pubmed ID: 18836658 Protein Kinase C Beta in Malignant Pleural Mesothelioma Anti-cancer Drugs. Oct, 2008 | Pubmed ID: 18765998 Phase I Trial of Erlotinib-based Multimodality Therapy for Inoperable Stage III Non-small Cell Lung Cancer Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. Sep, 2008 | Pubmed ID: 18758303 Expression and Mutational Analysis of MET in Human Solid Cancers Genes, Chromosomes & Cancer. Dec, 2008 | Pubmed ID: 18709663 Concerted Potent Humoral Immune Responses to Autoantigens Are Associated with Tumor Destruction and Favorable Clinical Outcomes Without Autoimmunity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2008 | Pubmed ID: 18559611 Erlotinib Plus Bevacizumab in Previously Treated Patients with Malignant Pleural Mesothelioma Cancer. Aug, 2008 | Pubmed ID: 18543326 Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. May, 2008 | Pubmed ID: 18483332 Efficacy and Safety of Bevacizumab Plus Erlotinib for Patients with Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: a Trial of the Chicago, PMH, and California Phase II Consortia Gynecologic Oncology. Jul, 2008 | Pubmed ID: 18423560 C. Elegans As a Model Organism for in Vivo Screening in Cancer: Effects of Human C-Met in Lung Cancer Affect C. Elegans Vulva Phenotypes Cancer Biology & Therapy. Jun, 2008 | Pubmed ID: 18340114 Randomized Phase II Study of Carboplatin and Etoposide with or Without the Bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-stage Small-cell Lung Cancer: CALGB 30103 Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2008 | Pubmed ID: 18281659 Paxillin is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion Cancer Research. Jan, 2008 | Pubmed ID: 18172305 Preclinical Studies of the Proteasome Inhibitor Bortezomib in Malignant Pleural Mesothelioma Cancer Chemotherapy and Pharmacology. Apr, 2008 | Pubmed ID: 17522864 Review of Clinic Trials: Agents Targeting C-Met Reviews on Recent Clinical Trials. May, 2007 | Pubmed ID: 18473999 Non-receptor Tyrosine Kinase Inhibitors in Lung Cancer Anti-cancer Agents in Medicinal Chemistry. Nov, 2007 | Pubmed ID: 18045058 CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity. Role of C-Met, Tiam1/Rac1, Dynamin 2, and Cortactin The Journal of Biological Chemistry. Oct, 2007 | Pubmed ID: 17702746 Lysophosphatidic Acid Modulates C-Met Redistribution and Hepatocyte Growth Factor/c-Met Signaling in Human Bronchial Epithelial Cells Through PKC Delta and E-cadherin Cellular Signalling. Nov, 2007 | Pubmed ID: 17689924 Chemotherapy and High Dose Radiotherapy Followed by Resection for Locally Advanced Nonsmall Cell Lung Cancers American Journal of Clinical Oncology. Jun, 2007 | Pubmed ID: 17551302 A Selective Small Molecule Inhibitor of C-Met, PHA665752, Inhibits Tumorigenicity and Angiogenesis in Mouse Lung Cancer Xenografts Cancer Research. Apr, 2007 | Pubmed ID: 17440059 Biomarker Discovery in Lung Cancer--promises and Challenges of Clinical Proteomics Mass Spectrometry Reviews. May-Jun, 2007 | Pubmed ID: 17407130 C-Met is a Potentially New Therapeutic Target for Treatment of Human Melanoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2007 | Pubmed ID: 17404109 Key Signaling Pathways and Targets in Lung Cancer Therapy Clinical Lung Cancer. Feb, 2007 | Pubmed ID: 17382025 Activation of HGF/c-Met Pathway Contributes to the Reactive Oxygen Species Generation and Motility of Small Cell Lung Cancer Cells American Journal of Physiology. Lung Cellular and Molecular Physiology. Jun, 2007 | Pubmed ID: 17322284 Tyrosine Kinase Mutations in Human Cancer Current Molecular Medicine. Feb, 2007 | Pubmed ID: 17311534 C-Met Overexpression is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion Cancer Research. Feb, 2007 | Pubmed ID: 17308108 C-Met and Hepatocyte Growth Factor: Potential As Novel Targets in Cancer Therapy Current Oncology Reports. Mar, 2007 | Pubmed ID: 17288874 Lung Carcinoma in African Americans Nature Clinical Practice. Oncology. Feb, 2007 | Pubmed ID: 17259932 A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non-small Cell Lung or Esophageal Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jan, 2007 | Pubmed ID: 17255273 A Review of Topoisomerase Inhibition in Lung Cancer Cancer Biology & Therapy. Dec, 2006 | Pubmed ID: 17224634 Epidermal Growth Factor Receptor - Mediated Signal Transduction in the Development and Therapy of Gliomas Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2006 | Pubmed ID: 17189397 C-Met Inhibition Clinical Advances in Hematology & Oncology : H&O. Nov, 2006 | Pubmed ID: 17143251 Epidermal Growth Factor Receptor Mutations and Susceptibility to Targeted Therapy in Lung Cancer Respirology (Carlton, Vic.). Nov, 2006 | Pubmed ID: 17052295 Diffuse Alveolar Damage After a Single Dose of Topotecan in a Patient with Pulmonary Fibrosis and Small Cell Lung Cancer Lung Cancer (Amsterdam, Netherlands). Nov, 2006 | Pubmed ID: 16949700 Gefitinib Response of Erlotinib-refractory Lung Cancer Involving Meninges--role of EGFR Mutation Nature Clinical Practice. Oncology. Jan, 2006 | Pubmed ID: 16407879 Functional Analysis of C-Met/hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma Cancer Research. Jan, 2006 | Pubmed ID: 16397249 Molecular Biology of Malignant Mesothelioma: a Review Hematology/oncology Clinics of North America. Dec, 2005 | Pubmed ID: 16325120 Expression of Siva-1 Protein or Its Putative Amphipathic Helical Region Enhances Cisplatin-induced Apoptosis in Breast Cancer Cells: Effect of Elevated Levels of BCL-2 Cancer Research. Jun, 2005 | Pubmed ID: 15958577 Therapeutic Targeting of Receptor Tyrosine Kinases in Lung Cancer Expert Opinion on Therapeutic Targets. Jun, 2005 | Pubmed ID: 15948672 C-Met As a Target for Human Cancer and Characterization of Inhibitors for Therapeutic Intervention Cancer Letters. Jul, 2005 | Pubmed ID: 15922853 Novel Therapies in Lung Cancer Hematology/oncology Clinics of North America. Apr, 2005 | Pubmed ID: 15833410 A Selective Small Molecule C-MET Inhibitor, PHA665752, Cooperates with Rapamycin Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2005 | Pubmed ID: 15788682 Functional Expression and Mutations of C-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non-small Cell Lung Cancer Cancer Research. Feb, 2005 | Pubmed ID: 15735036 Activation of the PI3K/mTOR Pathway by BCR-ABL Contributes to Increased Production of Reactive Oxygen Species Blood. Feb, 2005 | Pubmed ID: 15486067 Novel Targets for Therapeutic Agents in Small Cell Lung Cancer Journal of the National Comprehensive Cancer Network : JNCCN. Mar, 2004 | Pubmed ID: 19777705 The Role of Ephrins and Eph Receptors in Cancer Cytokine & Growth Factor Reviews. Dec, 2004 | Pubmed ID: 15561600 Modulation of C-Kit/SCF Pathway Leads to Alterations in Topoisomerase-I Activity in Small Cell Lung Cancer Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 2004 | Pubmed ID: 15511212 Receptor Tyrosine Kinases and Inhibitors in Lung Cancer TheScientificWorldJournal. Aug, 2004 | Pubmed ID: 15349502 Integrin-dependent Protein Tyrosine Phosphorylation is a Key Regulatory Event in Collagen-IV-mediated Adhesion and Proliferation of Human Lung Tumor Cell Line, Calu-1 The Annals of Thoracic Surgery. Aug, 2004 | Pubmed ID: 15276495 Therapeutic Targeting of the Receptor Tyrosine Kinase Met Cancer Treatment and Research. 2004 | Pubmed ID: 15164876 Haptoglobin Alpha-subunit and Hepatocyte Growth Factor Can Potentially Serve As Serum Tumor Biomarkers in Small Cell Lung Cancer Anticancer Research. Mar-Apr, 2004 | Pubmed ID: 15154618 Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2004 | Pubmed ID: 15131038 Targeting C-Kit Mutations: Basic Science to Novel Therapies Leukemia Research. May, 2004 | Pubmed ID: 15036937 Targeted Molecules in Small Cell Lung Cancer Seminars in Oncology. Feb, 2004 | Pubmed ID: 14981588 Small Cell Lung Cancer: from Molecular Biology to Novel Therapeutics Journal of Experimental Therapeutics & Oncology. Nov-Dec, 2003 | Pubmed ID: 14678519 Phase II Study of Imatinib in Patients with Small Cell Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2003 | Pubmed ID: 14676110 P53 and Bcl-2 in Small Cell-lung Cancer Clinical Lung Cancer. Mar, 2003 | Pubmed ID: 14609449 C-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions Cancer Research. Oct, 2003 | Pubmed ID: 14559814 Mechanisms of Metastasis As Related to Receptor Tyrosine Kinases in Small-cell Lung Cancer Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 2003 | Pubmed ID: 14529091 A Novel Small Molecule Met Inhibitor Induces Apoptosis in Cells Transformed by the Oncogenic TPR-MET Tyrosine Kinase Cancer Research. Sep, 2003 | Pubmed ID: 14500382 Recent Advances in the Molecular Biology, Diagnosis and Novel Therapies for Various Small Blue Cell Tumors Anticancer Research. Jul-Aug, 2003 | Pubmed ID: 12926079 C-Met: Structure, Functions and Potential for Therapeutic Inhibition Cancer Metastasis Reviews. Dec, 2003 | Pubmed ID: 12884908 Small-cell Cancers, and an Unusual Reaction to Chemotherapy. Case 1. Extrapulmonary Small-cell Carcinoma Arising in the Prostate Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2003 | Pubmed ID: 12805344 Unusual Problems in Breast Cancer and a Rare Lung Cancer Case. Case 4. Primary Lymphoepithelioma-like Carcinoma of the Lung Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jun, 2003 | Pubmed ID: 12775751 Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases Methods in Molecular Medicine. 2003 | Pubmed ID: 12710200 Circulating Tumor Cells and Serum Tumor Biomarkers in Small Cell Lung Cancer Anticancer Research. Jan-Feb, 2003 | Pubmed ID: 12683352 2-methoxyestradiol Alters Cell Motility, Migration, and Adhesion Blood. Jul, 2003 | Pubmed ID: 12637335 Molecular and Cellular Biology of Small Cell Lung Cancer Seminars in Oncology. Feb, 2003 | Pubmed ID: 12635090 Use of Temozolomide with Other Cytotoxic Chemotherapy in the Treatment of Patients with Recurrent Brain Metastases from Lung Cancer The Oncologist. 2003 | Pubmed ID: 12604733 Vaccination with Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-macrophage Colony-stimulating Factor Augments Antitumor Immunity in Some Patients with Metastatic Non-small-cell Lung Carcinoma Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2003 | Pubmed ID: 12586798 Role of Receptor Tyrosine Kinases in Lung Cancer Methods in Molecular Medicine. 2003 | Pubmed ID: 12415690 Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System Methods in Molecular Medicine. 2003 | Pubmed ID: 12407757 Molecular Alterations in Lung Cancer. Impact on Prognosis Methods in Molecular Medicine. 2003 | Pubmed ID: 12407733 Regulation of Cellular Proliferation, Cytoskeletal Function, and Signal Transduction Through CXCR4 and C-Kit in Small Cell Lung Cancer Cells Cancer Research. Nov, 2002 | Pubmed ID: 12414661 Inhibition of Epidermal Growth Factor Receptor Signaling in Malignant Pleural Mesothelioma Cancer Research. Sep, 2002 | Pubmed ID: 12234991 Flow Cytometric Determination of Lipid Peroxidation Using Fluoresceinated Phosphoethanolamine Methods in Enzymology. 2002 | Pubmed ID: 12125379 CD2 Molecules Redistribute to the Uropod During T Cell Scanning: Implications for Cellular Activation and Immune Surveillance Proceedings of the National Academy of Sciences of the United States of America. May, 2002 | Pubmed ID: 12032326 Gemcitabine-induced Radiation Recall International Journal of Radiation Oncology, Biology, Physics. Jun, 2002 | Pubmed ID: 12023144 ATP6S1 Elicits Potent Humoral Responses Associated with Immune-mediated Tumor Destruction Proceedings of the National Academy of Sciences of the United States of America. May, 2002 | Pubmed ID: 11983866 A Fragment of Paxillin Binds the Alpha 4 Integrin Cytoplasmic Domain (tail) and Selectively Inhibits Alpha 4-mediated Cell Migration The Journal of Biological Chemistry. Jun, 2002 | Pubmed ID: 11919182 Differential Expression and Signaling of CBL and CBL-B in BCR/ABL Transformed Cells Oncogene. Feb, 2002 | Pubmed ID: 11857085 Modulation of the C-Met/hepatocyte Growth Factor Pathway in Small Cell Lung Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Feb, 2002 | Pubmed ID: 11839685 Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells is Associated with Beta 1 Integrin- and Phosphatidylinositol 3-kinase-dependent PKC Alpha Activation The Journal of Biological Chemistry. Mar, 2002 | Pubmed ID: 11751905 Role of the Hepatocyte Growth Factor Receptor, C-Met, in Oncogenesis and Potential for Therapeutic Inhibition Cytokine & Growth Factor Reviews. Feb, 2002 | Pubmed ID: 11750879 Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research Mosmi Surati1, Matthew Robinson2, Suvobroto Nandi2, Leonardo Faoro2, Carley Demchuk2, Rajani Kanteti2, Benjamin Ferguson1, Tara Gangadhar2, Thomas Hensing3, Rifat Hasina2, Aliya Husain4, Mark Ferguson5, Theodore Karrison6, Ravi Salgia2 1Pritzker School of Medicine, University of Chicago, 2Department of Medicine, University of Chicago, 3Department of Medicine, Northshore University Health Systems, 4Department of Pathology, University of Chicago, 5Department of Surgery, University of Chicago, 6Department of Biostatistics, University of Chicago JoVE 2414 Medicine
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research Mosmi Surati1, Matthew Robinson2, Suvobroto Nandi2, Leonardo Faoro2, Carley Demchuk2, Rajani Kanteti2, Benjamin Ferguson1, Tara Gangadhar2, Thomas Hensing3, Rifat Hasina2, Aliya Husain4, Mark Ferguson5, Theodore Karrison6, Ravi Salgia2 1Pritzker School of Medicine, University of Chicago, 2Department of Medicine, University of Chicago, 3Department of Medicine, Northshore University Health Systems, 4Department of Pathology, University of Chicago, 5Department of Surgery, University of Chicago, 6Department of Biostatistics, University of Chicago JoVE 2414 Medicine